IPO Pipeline Update: New Filings & Updated Terms (Week ending 6.23.17)

New Filings & Updated Terms (Week ending 6.23.17)

IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included.

NEW FILINGS

Company: Vencore Holding Corp.
Symbol: VNCR
Description: Vencore is a leading provider of mission-critical, innovation-driven services and solutions to U.S. Government customers.
Trade Date: TBD
Underwriter(s): Goldman Sachs & Co., Wells Fargo Securities
Terms Added: 6-21-17
Listed Cash Raise: $250 million

Company: Kala Pharmaceuticals, Inc.
Symbol: KALA
Description: They are a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.
Trade Date: TBD
Underwriter(s): J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities
Co-Manager: Wedbush PacGrow
Filed: 6-23-17
Listed Cash Raise: $86.25 million

Company: Calyxt, Inc.
Symbol: TBD
Description: They are a consumer-centric, food- and agriculture-focused company. By combining our leading gene-editing technology and technical expertise with our innovative commercial strategy, we are pioneering a paradigm shift to deliver healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance, to farmers.
Trade Date: TBD
Underwriter(s): Citigroup, Credit Suisse, Jefferies, Wells Fargo Securities
Co-Manager: Ladenburg Thalmann
Filed: 6-23-17
Listed Cash Raise: $50 million

Company: YogaWorks, Inc.
Symbol: YOGA
Description: They are one of the largest and fastest growing providers of high quality yoga instruction in the U.S., with almost 3 million student visits in 2016 and 50 company-owned studios as well as our Internet-based digital media service, MyYogaWorks.com
Trade Date: TBD
Underwriter(s): Cowen and Company, Stephens Inc., Guggenheim Securities
Filed: 6-23-17
Listed Cash Raise: $74.75 million

Company: PetIQ, Inc.
Symbol: PETQ
Description: PetIQ is a rapidly growing distributor and manufacturer of veterinarian-grade pet prescription medications, over-the-counter flea and tick preventatives and health and wellness products for dogs and cats.
Trade Date: TBD
Underwriter(s): Jefferies, William Blair
Co-Manager(s): Oppenheimer & Co., Raymond James, SunTrust Robinson Humphrey
Filed: 6-23-17
Listed Cash Raise: $85 million

TERMS ADDED

Company: Esquire Financial Holdings
Symbol: ESQ
Description: They are a bank holding company headquartered in Jericho, New York and registered under the Bank Holding Company Act of 1956, as amended (the BHC Act).
Trade Date: 6/27
Price: $14.00-$16.00
Shares 2.56 million
Underwriter(s): Sandler O’ Neill + Partners
Terms Added: 6-19-17

Company: Dova Pharmaceuticals, Inc.
Symbol: DOVA
Description: They are a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count.
Trade Date: 6/28
Price Range: $15.00-$17.00
Shares: 4.06 million
Underwriter(s): J.P. Morgan, Jefferies, Leerink Partners
Terms Added: 6-19-17

Company: Byline Bancorp, Inc.
Symbol: BY
Description: They are a bank holding company headquartered in Chicago, Illinois and conduct all our business activities through our subsidiary, Byline Bank, a full service commercial bank.
Trade Date: 6/29
Price Range: $19.00-$21.00
Shares: 5.7 million
Underwriter(s): BofA Merrill Lynch, Keefe Bruyette & Woods
Co-Manager(s): Piper Jaffray, Sandler O’Neill + Partners, Stephens Inc.
Terms Added: 6-19-17

Company: Blue Apron Holdings, Inc.
Symbol: APRN
Description: Blue Apron was founded in 2012 premised on a simple desire—our founders wanted to cook at home with their families, but they found grocery shopping and menu planning burdensome, time consuming, and expensive.
Trade Date: 6/29
Price Range: $15.00-$17.00
Shares: 30 million
Underwriter(s): Goldman Sachs & Co., Morgan Stanley, Citigroup, Barclays
Co-Manager(s): RBC Capital Markets, SunTrust Robinson Humphrey, Stifel, Canaccord Genuity, Needham & Company, Oppenheimer & Co., Raymond James, William Blair
Terms Added: 6-19-17

Company: Aileron Therapeutics, Inc.
Symbol: ALRN
Description: They are a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
Trade Date: 6/29
Price Range: $15.00-$17.00
Shares: 3.75 million
Underwriter(s): BofA Merrill Lynch, Jefferies
Co-Manager(s): William Blair, Canaccord Genuity
Terms Added: 6-19-17

Company: Akcea Therapeutics, Inc.
Symbol: AKCA
Description: They are a late-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.
Trade Date: 6/30
Price Range: $12.00-$14.00
Shares: 9.62 million
Underwriter(s): Cowen and Company, Stifel, Wells Fargo Securities
Co-Manager(s): BMO Capital Markets
Terms Added: 6-20-17